BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 30143957)

  • 1. Expected Budget Impact and Health Outcomes of Expanded Use of Vagus Nerve Stimulation Therapy for Drug-Resistant Epilepsy.
    Purser MF; Mladsi DM; Beckman A; Barion F; Forsey J
    Adv Ther; 2018 Oct; 35(10):1686-1696. PubMed ID: 30143957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis.
    Chambers A; Bowen JM
    Ont Health Technol Assess Ser; 2013; 13(18):1-37. PubMed ID: 24228081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
    Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
    Eur J Paediatr Neurol; 2012 Sep; 16(5):449-58. PubMed ID: 22261080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy.
    Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
    Epilepsy Behav; 2011 Oct; 22(2):370-5. PubMed ID: 21872534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of vagus nerve stimulation on secondary care burden in children and adults with epilepsy: Review of routinely collected hospital data in England.
    Camp C; Smithson WH; Bunker M; Burke T; Hughes D
    Epilepsy Behav; 2015 Nov; 52(Pt A):68-73. PubMed ID: 26409132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Vagus Nerve Stimulation for the Treatment of Drug-resistant Epilepsy on Patterns of Use and Cost of Health Care Services and Pharmacotherapy: Comparisons of the 24-Month Periods Before and After Implantation.
    Evans K; Stamas N; Li Q; Vincent T; Halchenko Y; Zhang L; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
    Clin Ther; 2023 Feb; 45(2):136-150. PubMed ID: 36746736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vagus nerve stimulation therapy in a developing country: a long term follow up study and cost utility analysis.
    Aburahma SK; Alzoubi FQ; Hammouri HM; Masri A
    Seizure; 2015 Feb; 25():167-72. PubMed ID: 25468513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic and clinical evaluation of vagus nerve stimulation therapy.
    Kopciuch D; Barciszewska AM; Fliciński J; Paczkowska A; Winczewska-Wiktor A; Jankowski R; Steinborn B; Nowakowska E
    Acta Neurol Scand; 2019 Oct; 140(4):244-251. PubMed ID: 31165476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation
    Vincent T; Li Q; Zhang L; Stokes M; Danielson V; Murphy J; Barion F; Lam S; Lassagne R; Berger A
    J Med Econ; 2022; 25(1):1218-1230. PubMed ID: 36384429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety following two or more years of vagus nerve stimulation (VNS Therapy) in pediatric patients with drug-resistant epilepsy enrolled in a Russian VNS Registry.
    Feygina AA; Koshelyaevskaya YN; Dibué M; Voronkova KV; Klochkov MN; Koroleva NY; Ivanov SS; Bolshakova ES; Fatykhova EF
    Brain Behav; 2023 Jul; 13(7):e3076. PubMed ID: 37254623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of pharmacotherapy regimen and costs in patients with drug-resistant epilepsy following vagus nerve stimulation therapy: a single-center study (Poland).
    Kopciuch D; Barciszewska AM; Fliciński J; Zaprutko T; Kus K; Steinborn B; Nowakowska E
    Acta Neurol Belg; 2020 Feb; 120(1):115-122. PubMed ID: 31721076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of direct hospital costs before and 18 months after treatment with vagus nerve stimulation therapy in 43 patients.
    Ben-Menachem E; Hellström K; Verstappen D
    Neurology; 2002 Sep; 59(6 Suppl 4):S44-7. PubMed ID: 12270968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of the ketogenic diet and vagus nerve stimulation for the treatment of children with intractable epilepsy.
    de Kinderen RJ; Postulart D; Aldenkamp AP; Evers SM; Lambrechts DA; Louw AJ; Majoie MH; Grutters JP
    Epilepsy Res; 2015 Feb; 110():119-31. PubMed ID: 25616464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term seizure and psychosocial outcomes of vagus nerve stimulation for intractable epilepsy.
    Wasade VS; Schultz L; Mohanarangan K; Gaddam A; Schwalb JM; Spanaki-Varelas M
    Epilepsy Behav; 2015 Dec; 53():31-6. PubMed ID: 26515157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vagal nerve stimulation outcome, and laryngeal effect: Otolaryngologists roles and perspective.
    Al Omari AI; Alzoubi FQ; Alsalem MM; Aburahma SK; Mardini DT; Castellanos PF
    Am J Otolaryngol; 2017; 38(4):408-413. PubMed ID: 28390806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children.
    Orosz I; McCormick D; Zamponi N; Varadkar S; Feucht M; Parain D; Griens R; Vallée L; Boon P; Rittey C; Jayewardene AK; Bunker M; Arzimanoglou A; Lagae L
    Epilepsia; 2014 Oct; 55(10):1576-84. PubMed ID: 25231724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of vagus nerve stimulation therapy after failed epilepsy surgery.
    Vale FL; Ahmadian A; Youssef AS; Tatum WO; Benbadis SR
    Seizure; 2011 Apr; 20(3):244-8. PubMed ID: 21196125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vagus nerve stimulation for children with treatment-resistant epilepsy: a consecutive series of 141 cases.
    Elliott RE; Rodgers SD; Bassani L; Morsi A; Geller EB; Carlson C; Devinsky O; Doyle WK
    J Neurosurg Pediatr; 2011 May; 7(5):491-500. PubMed ID: 21529189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.